S Golding

Final results of the phase III, randomized, double-blind AVOREN trial of first-line bevacizumab (BEV) + interferon-α2a (IFN) in metastatic renal cell carcinoma (mRCC)

Bernard Escudier, Joaquim Bellmunt, S. Négrier et al. · Journal of Clinical Oncology · 2009 · 88 citations

Surgical Oncology, Avoren Trial, Clinical Endpoint +19

Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines

Robert J. Moots, Z Al-Saffar, David Hutchinson et al. · Annals of the Rheumatic Diseases · 1999 · 66 citations · Full text

Pre-synaptic NO-cGMP Pathway Modulates Vagal Control of Heart Rate in Isolated Adult Guinea Pig Atria

Neil Herring, S Golding, David J. Paterson · Journal of Molecular and Cellular Cardiology · 2000 · 63 citations

Heart Rate, Molecular Physiology, Physiology +6

Ceruloplasmin, transferrin and apotransferrin facilitate iron release from human liver cells

Stephen P. Young, Magdy Fahmy, S Golding · FEBS Letters · 1997 · 58 citations · Full text

Remodeling of the Cardiac Pacemaker L-Type Calcium Current and Its β-Adrenergic Responsiveness in Hypertension After Neuronal NO Synthase Gene Transfer

Daniel A. Heaton, Ming Lei, Dan Li et al. · Hypertension · 2006 · 36 citations · Full text

Hypertension, Cardiovascular Function, Social Sciences +17